Category: Musculoskeletal

Hammer toes are a common forefoot deformity in which one or more lesser toes bend at the middle joint, producing pain, corns, and difficulty with footwear. Treatment focuses first on relieving symptoms and preventing progression with conservative measures, and only then on corrective surgery if deformity and pain persist.

Goals of treatment

Management of hammer toes aims to:

• Reduce pain and pressure from shoes and ground contact.
• Correct or control the deforming forces (muscle imbalance, tight tendons, poor footwear).
• Prevent secondary problems such as corns, calluses, ulceration, and difficulty walking.
• Straighten the toe and restore function when possible, particularly with surgery in rigid cases.

The choice between non‑surgical and surgical treatment depends mainly on whether the toe is still flexible, the intensity of pain, and the impact on daily activities.

Conservative (non‑surgical) treatment

Non‑surgical treatment is the first line for flexible or mildly symptomatic hammer toes and often gives substantial relief.

1. Footwear modification
   • Patients are advised to avoid tight, narrow, and high‑heeled shoes that crowd the toes and increase pressure on the bent joint.
   • Recommended shoes have a wide, deep toe box and low heels, and are about half a size longer than the longest toe so that there is space for the deformity and any protective padding.
2. Padding, cushioning, and taping
   • Soft pads, sleeves, or cushioning over the prominent joint redistribute pressure and reduce friction, which helps relieve pain and prevents corns and calluses.
   • Taping or splinting the toe can hold it in a straighter position, temporarily correcting muscle imbalance and lessening irritation in shoes.
3. Orthotic devices and shoe inserts
   • Prefabricated or custom orthotic insoles support the arch and alter load distribution, reducing stress on the metatarsal region and toe joints
   • By improving foot biomechanics, orthotics may slow progression of the deformity, especially when hammer toe is associated with flat feet or other structural problems.
4. Exercises and stretching
   • Toe‑strengthening and stretching exercises are often prescribed when the toe is still flexible, such as picking up marbles with the toes or scrunching a towel, to improve intrinsic muscle balance.
   • Gentle manual stretches of the affected toe and calf‑muscle stretching can help reduce tendon tightness and maintain joint motion.
5. Medications and injections
   • Oral non‑steroidal anti‑inflammatory drugs (NSAIDs) can reduce pain and inflammation around the affected joints in symptomatic periods.
6. Skin and nail care
   • Regular debridement of corns and calluses by a podiatrist, combined with ongoing padding and proper footwear, reduces pain and risk of skin breakdown.
   • Patients at higher risk, such as those with diabetes or poor circulation, need careful monitoring to prevent ulcers over the prominent joints

Conservative care of hammer toes does not typically “reverse” an established deformity, but it often controls symptoms sufficiently that many patients avoid or delay surgery.

Indications for surgery

Surgery is considered when non‑surgical measures fail and the patient continues to have significant pain, difficulty wearing shoes, or functional limitations. Rigid toes that cannot be passively straightened, recurrent corns despite adequate footwear, and deformities causing ulceration are common indications.

Before surgery, clinicians assess:

• Flexibility of the toe (flexible vs fixed deformity).
• Condition of adjacent joints and overall foot alignment.
• Patient health, activity level, and expectations for recovery.

Most procedures are performed as day surgery with local or regional anesthesia.

Surgical techniques

The specific operation is tailored to the severity and rigidity of the toe deformity.

1. Soft‑tissue procedures (flexible hammer toes)
   • In flexible deformities, the main problem is often tendon and ligament imbalance, so operations aim to lengthen or transfer tendons without removing much bone.
   • Tendon lengthening reduces the excessive pull that keeps the toe bent, while tendon transfer (typically from the underside of the toe to the top) repositions the tendon so that it helps straighten and hold the toe down.
2. Bone procedures and joint resection (rigid hammer toes)
   • When the joint is stiff and fixed, surgeons may remove a small piece of bone from the proximal phalanx or the joint surfaces (arthroplasty) to allow the toe to straighten.nyp+3
   • In more severe deformities, the joint may be fused (arthrodesis) using pins, screws, or other implants, so the bone ends heal together into a single, straight segment that eliminates the painful motion.
3. Fixation and minimally invasive methods
   • Temporary pins are sometimes placed across the joint to maintain alignment while soft tissues and bone heal; they are usually removed after a few weeks once stability is achieved.
   • Some centres use key‑hole or minimally invasive techniques with small skin portals to cut bone and release soft tissues, aiming for less postoperative pain and swelling and quicker recovery.

Overall, the goal of surgery is to correct the deformity sufficiently to relieve pain and allow comfortable shoe wear, rather than to create a perfectly “normal‑looking” toe.mayoclinic+2

Postoperative care and outcomes

After hammer toe surgery, patients typically go home the same day in a protective shoe, with instructions to elevate the foot and limit weight‑bearing initially. Stitches and any external pins are removed after a short healing period, and patients gradually progress to normal footwear as swelling and tenderness settle, often over 4–6 weeks, with fuller return to all footwear and activities by around three months depending on the procedure.

Pain usually decreases significantly once healing has occurred, and most patients report improved shoe comfort and walking ability. However, there are recognised risks, including infection, stiffness, residual deformity, recurrence, or dissatisfaction with toe appearance, so careful patient selection and realistic preoperative counselling are essential. Even after surgery, ongoing attention to shoe choice and, where appropriate, orthotics and exercises remains important to protect the operated toe and prevent problems in adjacent toes.

Gout treatment focuses on rapidly controlling acute flares and preventing future attacks through long‑term urate lowering and lifestyle modification. Effective management requires matching therapy to comorbidities, using a treat‑to‑target serum urate strategy, and providing prophylaxis during urate‑lowering initiation.

Pathophysiological basis for treatment

Gout is an inflammatory arthritis caused by monosodium urate crystal deposition in and around joints, driven by sustained hyperuricaemia. When serum urate exceeds its solubility threshold, crystals form, triggering innate immune activation, particularly via NLRP3 inflammasome and interleukin‑1, and resulting in intense joint inflammation. Long‑standing hyperuricaemia leads to tophi, structural joint damage, and urate nephropathy, so treatment must both suppress inflammation and reduce the total body urate burden. This dual pathophysiological focus underpins the division of therapy into acute flare management and chronic urate‑lowering therapy.

Management of acute gout flares

Acute flares should be treated as early as possible, ideally within the first 24 hours of symptom onset, to shorten duration and reduce pain. First‑line options with broadly similar efficacy are non‑steroidal anti‑inflammatory drugs (NSAIDs), colchicine, and systemic or intra‑articular glucocorticoids, with the choice determined by comorbidities, contraindications, and patient preference

NSAIDs such as naproxen, indomethacin, or sulindac are effective when given at full anti‑inflammatory doses until at least one to two days after complete resolution of the flare. They are often avoided in patients with advanced renal impairment, peptic ulcer disease, heart failure, or significant cardiovascular disease, and gastroprotective strategies may be necessary in higher‑risk individuals. Colchicine, using modern low‑dose regimens (for example 1.2 mg followed by 0.6 mg one hour later, or 0.5–0.6 mg two to three times daily), offers similar pain relief to NSAIDs while reducing gastrointestinal toxicity compared with older high‑dose protocols. Dose reduction and careful monitoring are required in renal or hepatic impairment and when patients are taking interacting drugs such as certain macrolides or statins.

Systemic glucocorticoids, such as oral prednisolone 30–35 mg once daily for about five days, provide an alternative when NSAIDs and colchicine are contraindicated or not tolerated. Intra‑articular corticosteroid injection is particularly useful for monoarticular flares when septic arthritis has been excluded. Where standard therapies are unsuitable, interleukin‑1 blockade (for example anakinra) can be considered for refractory or complex flares, especially in the acute medical setting, although cost and availability limit use. Combining NSAIDs or glucocorticoids with colchicine may be necessary for very severe attacks, but concurrent use of oral NSAIDs and glucocorticoids is generally avoided because of increased gastrointestinal bleeding risk.

Urate‑lowering therapy and treat‑to‑target approach

Long‑term management aims to prevent further attacks, resolve tophi, and halt structural damage by achieving and maintaining target serum urate levels. Contemporary guidelines advocate a treat‑to‑target strategy: most patients should aim for serum urate below 360 µmol/L, with a more stringent target below 300 µmol/L in those with tophi, frequent flares, or severe chronic gouty arthropathy. Urate‑lowering therapy (ULT) is strongly recommended for patients with recurrent flares, tophi, urate nephrolithiasis, or radiographic damage, and many guidelines now support offering ULT earlier, including after a first flare in high‑risk individuals with very high urate or significant comorbidities.

Allopurinol, a xanthine oxidase inhibitor, is the preferred first‑line ULT for most patients because of its effectiveness, cost, and long experience of use. Standard practice is to “start low and go slow”, typically initiating at 50–100 mg daily (lower in advanced chronic kidney disease) and titrating every few weeks until the target serum urate is achieved. Screening for HLA‑B*5801 is recommended in some populations, particularly those of East Asian ancestry, because of the higher risk of allopurinol hypersensitivity syndrome in carriers. Febuxostat, another xanthine oxidase inhibitor, is an alternative when allopurinol is contraindicated, not tolerated, or insufficient at maximally tolerated doses; it reduces serum urate more effectively than standard‑dose allopurinol in many trials, including in patients with renal impairment.

Uricosuric agents, which enhance renal urate excretion, such as probenecid or benzbromarone (availability varies by jurisdiction), may be used as second‑line therapy or in combination with xanthine oxidase inhibitors for difficult‑to‑control disease. In severe, refractory tophaceous gout, intravenous pegylated uricase (for example pegloticase) offers rapid urate lowering and tophus resolution but is reserved for selected patients because of cost, infusion reactions, and the need for specialist supervision. Whatever agent is chosen, achieving and maintaining the serum urate target over the long term is more important than the specific drug, and lifelong therapy is often required.

Flare prophylaxis when starting ULT

Initiation of ULT can paradoxically precipitate gout flares as changing serum urate destabilises existing crystal deposits. To mitigate this, guidelines recommend concurrent prophylactic anti‑inflammatory therapy for at least three to six months after starting or escalating ULT. Low‑dose colchicine (for example 0.5–0.6 mg once or twice daily) is generally preferred where tolerated, with dose adjustment in renal or hepatic impairment and attention to drug interactions. Alternatives include low‑dose NSAIDs, such as naproxen 250–500 mg once or twice daily, or low‑dose prednisolone around 5 mg daily when colchicine and NSAIDs are unsuitable. Continuing prophylaxis until serum urate has been at target for several months reduces early flare burden and supports adherence to ULT.

Lifestyle and comorbidity management

Non‑pharmacological measures complement drug treatment but rarely suffice alone in established gout. Dietary advice typically emphasises limiting purine‑rich meats and seafood, reducing alcohol (especially beer and spirits), avoiding excess fructose‑sweetened beverages, and encouraging weight loss in people with obesity. Adequate hydration, choosing low‑fat dairy products, and increasing vegetable intake may help modestly lower serum urate and improve metabolic health. Optimising associated conditions such as hypertension, chronic kidney disease, diabetes, metabolic syndrome, and heart failure is essential, since these comorbidities both predispose to gout and influence the safety profile of gout medications.

Patient education and shared decision‑making are central to successful long‑term management. Explaining that gout is a chronic, curable crystal deposition disease rather than an inevitable consequence of ageing improves motivation for sustained urate‑lowering therapy. Structured follow‑up to monitor serum urate, assess adherence, adjust therapy, and reinforce lifestyle advice supports durable control and can ultimately lead to complete resolution of flares and tophi for many patients.

Heel lifts are commonly used in clinical practice to manage foot and ankle pain, particularly conditions affecting the plantar heel and Achilles tendon, but the evidence base is mixed and often low quality. They appear to offer short‑term pain relief and functional improvement in selected patients, while their long‑term efficacy and ideal prescription parameters remain uncertain.

Rationale and proposed mechanisms

Heel lifts elevate the calcaneus relative to the forefoot, effectively plantarflexing the ankle and altering load distribution through the foot and lower limb. By reducing peak ankle dorsiflexion and shortening the gastrocnemius–Achilles complex, heel lifts are thought to decrease tensile and compressive loads on painful tissues such as the plantar fascia and Achilles tendon insertion. Biomechanical studies in asymptomatic individuals demonstrate that heel lifts of 10–18 mm can reduce maximum ankle dorsiflexion angle, shorten gastrocnemius–tendon unit length during running, and modify muscle activation patterns, supporting a mechanical basis for symptom change. In addition, elevating the heel can redistribute plantar pressures away from the posterior calcaneus, which may be particularly relevant in plantar heel pain and calcaneal spur–related discomfort.

Evidence in plantar heel pain

Several clinical and quasi‑experimental studies have evaluated heel elevation or heel lifts in plantar heel pain, though most are small and at high risk of bias. A systematic review of heel lifts for lower limb musculoskeletal conditions found very low‑certainty evidence from a single trial (n = 62) that heel lifts improved pain and function more than indomethacin at 12 months in plantar heel pain, as measured by the Foot Function Index. Another trial in calcaneal apophysitis suggested that custom orthoses were superior to simple heel lifts for pain relief at 12 weeks, indicating that a heel lift alone may be less effective than more comprehensive orthotic interventions in some paediatric presentations. Outside formal trials, a small study of patients with radiographic heel spurs showed that increasing shoe heel height reduced plantar heel pain in most individuals over eight weeks, with optimal relief at heel heights of 3–4 cm, presumably by lowering plantar forces under the calcaneus.

These findings suggest that heel lifts can reduce plantar heel pain for some patients, but they also highlight heterogeneity in response and the importance of individual foot morphology. For example, work by Kogler and colleagues (summarised in a narrative review) indicates that arch configuration may influence how heel elevation affects plantar fascia strain, implying that some arch types may benefit more from this strategy than others. Clinically, this supports using heel lifts as part of a broader management plan that may include stretching, load management, strengthening, and, where indicated, custom foot orthoses, rather than as a stand‑alone cure.

Use in Achilles tendinopathy

Heel lifts are widely advocated in Achilles tendinopathy due to their capacity to reduce dorsiflexion range and potentially decrease tendon loading during walking and running. A systematic review of heel lifts reported low‑ to moderate‑certainty evidence that, in at least one trial of mid‑portion Achilles tendinopathy, heel lifts were superior to eccentric calf exercise alone in reducing pain severity and improving VISA‑A scores at 12 weeks, with similar rates of minor adverse events such as new areas of musculoskeletal pain or blisters. More recent work in insertional Achilles tendinopathy has reinforced this potential benefit: a prospective study showed immediate reduction in pain during gait and improvement in symptom severity after two weeks of using in‑shoe heel lifts, along with positive changes in gait parameters such as walking speed and stride length. Biomechanically, these effects may relate to increased distance between the tendon and calcaneus in static stance and altered stance‑phase sub‑phase timing, including increased load response and decreased preswing duration.

Randomised feasibility work, such as the LIFTIT trial for insertional Achilles tendinopathy, indicates that a fully powered trial comparing heel lifts with sham devices is feasible and that preliminary data “signal” improvements in pain, function, physical activity, and quality of life with heel lifts. However, these pilot studies are not powered to definitively establish efficacy, and planned large‑scale trials like the LIFT trial for mid‑portion Achilles tendinopathy are still underway or recently initiated. Thus, while clinical and early trial evidence support the short‑term use of heel lifts as part of conservative care for Achilles tendinopathy, there is still uncertainty about optimal lift height, duration of use, and comparative effectiveness against other evidence‑based treatments such as heavy–slow resistance programs.

Broader biomechanical and clinical considerations

Beyond plantar heel pain and Achilles tendinopathy, heel lifts can influence global lower limb biomechanics, which has potential benefits and risks. Studies have shown that heel elevation during walking, running, or squatting can reduce ankle dorsiflexion demands, increase ankle work contribution, and modify activation of key muscles including the gastrocnemius, vastus lateralis, biceps femoris, and tibialis anterior. These changes may help clinicians offload painful structures, facilitate certain rehabilitation exercises, or accommodate limited ankle dorsiflexion in patients with equinus or post‑surgical stiffness. On the other hand, narrative reviews caution that higher heel elevations—whether via lifts or high‑heeled footwear—can alter gait patterns, increase fall and inversion sprain risk, and shift plantar pressure to the forefoot, potentially provoking new symptoms in the forefoot, knee, hip, or lumbar spine.

In addition, heel lifts may trigger neuromuscular responses that increase calf muscle activity, which is not uniformly beneficial; in some individuals this might aggravate posterior chain symptoms rather than relieve them. Adverse events reported in trials include development of new pain in the lower back, hips, knees, feet, or ankles, as well as skin irritation and blisters, although overall rates appear similar to comparison interventions. These findings underline the importance of careful patient selection, gradual introduction, and close monitoring when using heel lifts, particularly in individuals with complex multi‑site pain or balance impairments.

Clinical application and future directions

In practice, heel lifts are best viewed as a supportive adjunct rather than a definitive treatment for foot pain. For plantar heel pain, a modest, removable heel lift can be trialled alongside education, activity modification, plantar fascia–focused strengthening, and calf stretching, with close attention to changes in pain, function, and plantar pressure distribution. For mid‑portion and insertional Achilles tendinopathy, heel lifts may be particularly useful in the early, irritable phase to reduce pain during gait and exercise, potentially improving adherence to progressive loading programs. Clinicians should individualise lift height, usually starting with small increments (for example 6–10 mm) and adjusting based on symptom response and gait observation, while monitoring for secondary issues such as forefoot overload.

From a research perspective, the current literature is characterised by small samples, heterogeneous protocols, and low‑certainty evidence, despite promising signals of benefit in specific conditions. Ongoing and future randomised controlled trials comparing heel lifts with sham devices, custom orthoses, and established exercise programs will be critical to defining their true clinical value, cost‑effectiveness, and ideal prescription parameters. Until then, heel lifts should be prescribed judiciously, with clear expectations communicated to patients that they are one component of a multimodal strategy aimed at reducing pain, optimising load, and facilitating return to function rather than a stand‑alone cure.

Foot orthotics are widely used medical devices designed to support, align, and improve the function of the foot and lower limb. They play an important role in managing pain, optimising biomechanics, and preventing injury across a range of patient populations, from high‑performance athletes to people with chronic disease.

Definition and Types of Foot Orthotics

Foot orthotics (or foot orthoses) are external devices placed inside footwear to modify the mechanical function of the foot and lower limb. They are typically used to support arches, redistribute plantar pressures, and influence joint motion throughout the kinetic chain.

Broadly, orthotics are classified as:

• Prefabricated (off‑the‑shelf) devices, manufactured to generic foot shapes and conditions.
• Custom‑made devices, fabricated from a 3D representation of an individual’s foot (plaster, foam, or digital scan) and prescribed after a biomechanical assessment.

They can also be described by function: accommodative orthoses, made from softer materials to cushion and relieve pressure; and functional orthoses, often more rigid or semi‑rigid, aimed at controlling motion, particularly excessive pronation or supination. This basic taxonomy underpins clinical decision‑making when matching device type to pathology and patient goals.

Biomechanical Rationale and Mechanisms of Action

The use of foot orthotics rests on the principle that altering foot–ground interaction can change forces and motion throughout the lower limb. Orthoses can redistribute plantar pressure away from painful or high‑risk areas, such as metatarsal heads or the medial heel, by increasing contact area and supporting the longitudinal and transverse arches.

By contouring to the plantar surface and incorporating posting or wedging, orthotics can influence rearfoot and forefoot position in stance and gait. Controlling excessive pronation, for example, can reduce internal tibial rotation and downstream stresses at the knee and hip, while improving alignment may lessen compensatory muscle activity and fatigue. In addition, materials with shock‑absorbing properties attenuate impact forces during walking and running, which can reduce repetitive loading on bones, joints, and soft tissues.

Clinical Indications and Therapeutic Benefits

Foot orthotics are prescribed for a wide range of musculoskeletal and systemic conditions affecting the feet and lower limbs. Common indications include plantar fasciitis, posterior tibial tendon dysfunction, metatarsalgia, and mechanical heel pain, where orthoses help offload symptomatic tissues and support strained structures. They are also used in patients with flat feet or high arches to improve stability, distribute pressure more evenly, and reduce localised discomfort.

Beyond local foot pathology, orthoses may assist in managing shin splints, patellofemoral pain, and some presentations of knee, hip, or lower back pain when these are driven or exacerbated by abnormal foot mechanics. In people with diabetes or peripheral neuropathy, accommodative orthotics and total‑contact insoles are integral to ulcer prevention strategies because they reduce peak plantar pressures and shear in high‑risk areas. In the athletic population, orthotics are employed both as a treatment and as a preventive measure, with evidence suggesting reductions in overuse injuries and stress fractures in certain sporting cohorts.

Role in Performance, Function, and Quality of Life

Although their primary purpose is therapeutic, foot orthotics can also contribute to improved functional performance. By optimising alignment and enhancing stability, they may facilitate more efficient gait and running mechanics, allowing improved propulsion and reduced perceived exertion in some individuals. Enhanced shock absorption and pressure distribution can translate to greater comfort during prolonged standing, walking, or sport, which indirectly supports performance by delaying fatigue.

Importantly, orthotics can have a substantial impact on quality of life. For people whose activity is limited by chronic foot or lower limb pain, an effective orthotic prescription can restore the capacity to work, exercise, and participate in daily tasks. In older adults, improved stability and balance from appropriate footwear and orthoses may reduce fall risk and increase confidence in mobility. These functional gains underscore the broader health value of orthotic therapy beyond local symptom relief.

Limitations, Risks, and Considerations in Prescription

Despite their benefits, foot orthotics are not a universal solution and must be prescribed judiciously. Poorly indicated or poorly fitted devices can provoke new symptoms, such as pressure lesions, altered gait patterns, or pain elsewhere in the kinetic chain. Patients may also experience an adaptation period with transient discomfort as tissues adjust to altered loading.

Cost is a relevant limitation, especially for custom devices, and can affect adherence. Moreover, orthotics should rarely be used in isolation. Best‑practice management typically integrates them with footwear modification, targeted exercise therapy, load management, and, when appropriate, weight management or workplace changes. Long‑term or repeated use without periodic review may be problematic, as materials wear, patient biomechanics change, and underlying conditions evolve. Regular reassessment helps determine whether the device is still necessary, needs modification, or can be weaned.

Conclusion

The use of foot orthotics represents a key conservative intervention in contemporary lower‑limb care. By modifying foot function and load distribution, orthoses can relieve pain, prevent injury, and support better movement across diverse patient groups. Their effectiveness, however, depends on careful assessment, appropriate device selection, and integration into a broader, evidence‑based treatment plan that considers the whole person rather than the foot in isolation

Foot manipulation is a broad term encompassing joint mobilisation, high‑velocity manipulative thrusts, and soft‑tissue techniques applied to the foot and ankle to relieve pain and improve function. Within contemporary foot care, these interventions sit alongside exercise, taping, orthoses and footwear modification rather than replacing them, and the evidence suggests that their benefits are often adjunctive and condition‑specific rather than universally transformative.

Concepts and mechanisms

Foot manipulation and mobilisation target the numerous synovial joints of the foot and ankle, including the talocrural, subtalar, midtarsal and tarsometatarsal articulations. Techniques may involve low‑grade oscillatory glides, end‑range mobilisation with movement, or high‑velocity, low‑amplitude (HVLA) thrusts intended to overcome perceived joint restriction and reposition articular surfaces.

The proposed mechanisms of pain relief include:

• Mechanical effects, such as restoring joint play, reducing positional faults (for example at the calcaneocuboid joint), and improving load distribution across plantar soft tissues.
• Neurophysiological effects, in which rapid or sustained joint and soft‑tissue input modulates nociceptive processing and muscle tone, producing immediate but sometimes transient reductions in pain.
• Indirect biomechanical changes, including improved dorsiflexion or midfoot mobility that may reduce tensile and compressive stresses on structures such as the plantar fascia or tibialis posterior tendon.

Evidence in plantar heel pain

Plantar fasciitis, or plantar heel pain, is one of the most frequently studied conditions in relation to manual therapy of the foot. A randomized study comparing three protocols—foot and ankle manipulation plus cross‑friction massage, stretching of the gastroc‑soleus complex plus cross‑friction massage, and a combination of all three—found that all groups experienced meaningful reductions in pain and disability and improved ankle dorsiflexion. In that trial, stretching plus cross‑friction massage produced the greatest overall improvement in pain and function, while protocols that included manipulation produced larger gains in plantarflexion range.

Another single‑blind randomized controlled trial examined the effect of adding ankle, subtalar and midfoot mobilisations to a standard regimen of stretching and therapeutic ultrasound in patients with plantar fasciitis. Both groups improved in pain scores and function, but there was no statistically or clinically significant additional benefit from the joint mobilisation component, suggesting that for many patients soft‑tissue and exercise interventions may be sufficient.

Myofascial and trigger‑point manual therapy directed at muscles associated with plantar heel pain (such as gastrocnemius, soleus and intrinsic foot muscles) has also been studied. In one trial, the addition of specific trigger‑point manual therapies to a self‑stretching protocol yielded superior short‑term reductions in pain and better improvements in physical function when compared with stretching alone, with effect sizes that exceeded accepted minimal clinically important differences. Collectively, these findings suggest that while joint manipulation per se may not always outperform conventional care, targeted manual therapy—especially when combined with stretching—can enhance outcomes in plantar heel pain

Cuboid syndrome and midfoot pain

Cuboid syndrome, often described as a subtle subluxation or loss of congruity at the calcaneocuboid joint, represents one of the clearest indications where cuboid manipulation is regarded as a primary intervention. It typically follows an inversion–plantarflexion injury or repetitive overload and presents with lateral midfoot pain, tenderness over the cuboid, and pain on push‑off.

Manual techniques such as the “cuboid whip” and “cuboid squeeze” are designed to rapidly restore the calcaneocuboid relationship. Case‑based literature and critical appraisals report that many patients experience immediate and substantial relief after successful cuboid manipulation, sometimes returning to sport the same day in acute cases. In a case report of posterior tibialis tendinopathy associated with cuboid mobility restriction, a single cuboid whip manipulation normalized midtarsal pronation and reduced pain to 0/10 immediately, far surpassing the partial relief obtained from prior soft‑tissue work, stretching and taping.

However, symptom duration appears to influence response: reviews note that patients with cuboid syndrome present for a month may need several manipulations, and chronic cases of more than six months’ duration may require months of combined care despite immediate partial improvement after each manipulation. Current appraisals emphasise that high‑quality randomized trials are lacking, but support manipulation as part of a conservative package alongside rest, strengthening, padding and taping, with surgery reserved for rare refractory presentations.

Foot mobilisation therapy in practice

Beyond distinct syndromes, some practitioners employ broader Foot Mobilisation Therapy (FMT) or similar frameworks aimed at systematically mobilising multiple foot and ankle joints to restore what is described as normal joint function and range. Such approaches are commonly marketed for chronic, non‑specific foot pain, stiffness, or recurring overuse injuries, with the rationale that improving joint mobility and alignment can reduce compensatory stresses throughout the kinetic chain.

Evidence directly evaluating global foot mobilisation protocols is limited and heterogeneous, often consisting of clinical experience, case series and small trials rather than large, definitive randomized studies. Nonetheless, clinical reports and practitioner‑level syntheses highlight improvements in dorsiflexion, symptom severity and gait comfort in conditions such as subacute ankle sprains when Mulligan‑style mobilisation with movement is applied, reinforcing the concept that joint‑directed manual therapy can be a useful adjunct in selected musculoskeletal presentations.

Clinical integration and limitations

Across conditions, a consistent theme is that manipulation and manual therapy are most effective when integrated into a multimodal management plan rather than used in isolation. Typical adjuncts include stretching of the gastrocnemius–soleus complex and plantar fascia, intrinsic and extrinsic muscle strengthening, taping, orthotic or footwear modification, load management and patient education. In plantar heel pain and many overuse conditions, high‑quality studies show that exercise and soft‑tissue strategies alone can produce substantial benefit, with manipulation adding little or only short‑term change for some patients.

There are also clear limitations to what manipulation can achieve. Structural deformities, advanced degenerative changes, inflammatory arthropathies and neuropathic pain will not be “corrected” by joint manipulation, and inappropriate or repeated thrust techniques in the presence of instability, fracture, severe osteoporosis or vascular compromise may be harmful. For these reasons, current expert opinion stresses careful differential diagnosis, awareness of red flags, and the need to reserve manipulative procedures for clearly indicated mechanical dysfunctions, with informed consent and conservative dosing.

In summary, foot manipulation occupies a nuanced role in the treatment of foot pain: it can provide rapid and sometimes dramatic relief in specific mechanical syndromes such as cuboid syndrome, and it may enhance short‑term outcomes when combined with stretching and soft‑tissue work in plantar heel pain. Yet, for many common foot conditions, the best outcomes arise from a broader, evidence‑informed programme in which manual therapy is one tool among many, tailored to the individual’s pathology, biomechanics and functional goals rather than applied as a stand‑alone cure.

Forefoot supinatus is an acquired, soft-tissue–based deformity in which the forefoot becomes held in an inverted (supinated) position relative to the rearfoot, usually as a compensation to excessive pronation and flatfoot mechanics. It is flexible or reducible in its early stages, can mimic true forefoot varus, and plays an important role in the development and persistence of abnormal gait, pain, and overuse injury in the lower limb. Understanding its definition, biomechanics, differentiation from structural deformities, clinical features, and treatment options is essential for accurate diagnosis and effective management in podiatry and musculoskeletal practice.

Definition and biomechanics

Forefoot supinatus is defined as an acquired soft tissue contracture that holds the forefoot in a supinated or inverted position about the joints of the midfoot, rather than a fixed bony malalignment. In this condition, the medial column (first ray and adjacent structures) tends to be dorsiflexed and inverted relative to the rearfoot, producing an apparent forefoot varus when the subtalar joint is placed in neutral.

Biomechanically, the deformity develops as an adaptive response to chronic pronation of the subtalar and midtarsal joints, particularly in adult acquired flatfoot. Excessive calcaneal eversion forces the midtarsal joint to supinate about its longitudinal axis and often dorsiflexes the first ray, so that over time the soft tissues adapt and hold the forefoot in an inverted position even when the pathologic forces are reduced.

Aetiology and pathogenesis

Forefoot supinatus arises secondarily to pathological forces that either dorsiflex the medial metatarsals or prevent their plantarflexion during gait. Two major mechanisms are commonly highlighted: ankle equinus (limited ankle dorsiflexion) and excessive subtalar joint pronation, both of which increase forefoot loading in a way that promotes inversion and soft tissue contracture of the medial column.

With excessive calcaneal eversion, the forefoot is forced to invert about the midtarsal longitudinal axis to maintain contact with the ground, and the medial column dorsiflexes and becomes hypermobile. Over time, this repeated compensation leads to adaptive shortening of capsular and ligamentous structures, so that the inverted forefoot position becomes semi-fixed; according to Davis’s law, soft tissues remodel in response to chronic mechanical stress, reinforcing the acquired deformity.

Distinction from forefoot varus

Forefoot supinatus is often confused with forefoot varus, yet the two have different origins and clinical implications. Forefoot varus is classically described as a congenital, osseous deformity in which the forefoot is structurally inverted relative to the rearfoot when the subtalar joint is neutral, thereby inducing subtalar pronation to bring the medial forefoot to the ground.

By contrast, forefoot supinatus is an acquired, soft-tissue deformity that develops because of subtalar joint pronation rather than causing it, meaning it is a result rather than a primary driver of overpronation. A practical distinction is that supinatus is typically reducible—manual plantarflexion of the medial column can correct the apparent varus—whereas a true forefoot varus remains inverted even when soft tissues are stretched, reflecting its bony origin.

Clinical presentation and assessment

Clinically, patients with forefoot supinatus frequently present in the context of flatfoot deformity, overpronation, or adult acquired flatfoot, often accompanied by medial arch collapse and calcaneal eversion. Symptoms can include plantar fasciitis, metatarsalgia, callus formation under the metatarsal heads, and proximal overuse problems such as shin splints or knee and hip pain associated with altered pronation–supination mechanics.

On examination, the forefoot appears inverted relative to the rearfoot in subtalar neutral, but this inversion can often be reduced by manually plantarflexing the first ray and medial column, revealing the flexible nature of the deformity. Specific clinical tests, sometimes referred to as supinatus–varus tests, are used to differentiate supinatus from structural forefoot varus, as misclassification can lead to inappropriate orthotic posting and worsening of midfoot stress.

Management and clinical significance

Management of forefoot supinatus focuses on addressing the underlying biomechanical causes while gradually reducing the soft tissue contracture of the medial column. Treatment strategies may include calf stretching for equinus, strengthening and neuromuscular training of the intrinsic and extrinsic foot muscles, and carefully designed orthoses that avoid excessive medial forefoot posting in a reducible supinatus deformity.

If a supinatus deformity is treated as a fixed forefoot varus with rigid medial forefoot posting, abnormal stresses can occur at the first tarsometatarsal joint and along the medial column, potentially leading to pain, exostosis, and further dysfunction. Recognising forefoot supinatus as an acquired, potentially reversible soft-tissue adaptation enables more conservative, tissue-friendly interventions and may improve outcomes for patients with flatfoot-related pain and overuse injuries.

Fibromyalgia often causes pain, stiffness, and abnormal sensitivity in the feet, which can make standing, walking, and wearing shoes unusually difficult and exhausting. These foot symptoms can significantly limit mobility and reduce quality of life for many people living with this condition.

What fibromyalgia is

Fibromyalgia is a long‑term pain condition in which the nervous system becomes unusually sensitive and amplifies pain signals from the body. Instead of acting as a normal filter, the brain and spinal cord overreact to touch, pressure, movement, and even temperature, so sensations that would not normally hurt can become painful.

Beyond pain, fibromyalgia is linked with fatigue, non‑restorative sleep, and problems with concentration, all of which can worsen the experience of foot pain and make day‑to‑day activities harder.

How it affects foot tissues

Fibromyalgia does not damage bones or joints directly, but it can affect muscles, ligaments, fascia, and nerves in the feet. Muscles that support the arch and control the toes may become tense and tender, while ligaments and fascia, such as the plantar fascia along the sole, can feel tight or sore, especially with prolonged standing. Nerve fibers in the feet may also become hypersensitive, sending stronger pain messages than normal when they are compressed by shoes or stressed by walking.

Some people with fibromyalgia also have structural or biomechanical issues, such as flat feet, high arches, or over‑pronation, which can interact with the sensitized nervous system and further increase foot discomfort. When the arch collapses or the foot rolls inward, pressure shifts to different areas of the sole, and in fibromyalgia even these normal mechanical stresses can be perceived as intense pain.

Symptoms in the feet

Studies suggest that roughly half of people with fibromyalgia report pain in one or both feet, much more often than in people without the condition. Foot pain may be described as burning, aching, stabbing, throbbing, or a sensation like walking on bruises or pebbles, and it often affects the soles, heels, sides, or tops of the feet. Many people notice that the first steps in the morning or after sitting feel especially painful or stiff, and even light pressure from socks or shoe uppers can be uncomfortable because of heightened sensitivity.

In addition to pain, there can be tingling, numbness, or “pins and needles,” which reflect nerve involvement or co‑existing conditions such as small‑fiber neuropathy. Tender points or trigger points in the feet—small, very sensitive spots in muscles or fascia—may cause sharp localized pain when pressed and can refer discomfort along the arch or into the toes. Stiffness in the small joints and soft tissues can make the feet feel wooden or inflexible, particularly after rest.

Effects on walking and daily life

Because the feet bear body weight with every step, fibromyalgia‑related foot pain often changes the way a person walks. Research shows that people with fibromyalgia tend to walk more slowly and take shorter steps, which may be a protective response to pain in the soles and ankles. This altered gait can in turn strain the knees, hips, and lower back, adding new areas of discomfort and contributing to overall physical deconditioning.

Everyday activities that rely on standing or walking can become draining or feel nearly impossible on bad days. Tasks such as grocery shopping, work that requires prolonged standing, or social events that involve walking long distances may be limited or avoided, which reduces participation in work, exercise, and leisure and often worsens mood and sleep.

Management and support

Managing fibromyalgia‑related foot problems usually involves a mix of nervous‑system‑focused treatments and practical foot care strategies. Approaches may include gentle physical therapy, stretching of the calf and plantar fascia, supportive footwear or custom orthotics to improve alignment, and pacing activities to prevent overloading the feet. Some people also benefit from medications used in fibromyalgia, such as those that calm nerve activity, alongside local measures like ice or heat, soft insoles, and targeted work on trigger points.

Addressing sleep, stress, and general fitness is important, because poor sleep and high stress can increase pain sensitivity and make foot symptoms feel more severe. Education about why the feet hurt in fibromyalgia can reduce fear and help people choose supportive habits—such as regular low‑impact movement and comfortable, properly fitted shoes—that protect the feet while still keeping them as active as possible.

Fisiocrem is a topical gel widely used for the temporary relief of muscle and joint pain, particularly in active individuals and people with mild arthritis or age‑related discomfort. It combines several plant-derived ingredients with menthol to provide a cooling, soothing effect and support short-term pain management when applied directly to the skin.

What Fisiocrem Is

Fisiocrem is a non‑prescription topical preparation available mainly as a gel for muscle pain (often called Solugel) and as a joint‑focused version for mild arthritis and joint stiffness. It is marketed for muscular aches, joint discomfort, strains, sprains, bruises, and everyday overuse injuries that do not require emergency medical care.

The formulation typically includes menthol and plant extracts such as arnica, hypericum (St John’s Wort), calendula, melaleuca, and, in some joint products, boswellia and nigella. These ingredients are chosen for their traditional roles in easing pain, supporting tissue healing, and reducing mild inflammation in muscles and joints

Active Ingredients and Their Roles

Arnica is frequently used in topical products for bruises, soft‑tissue trauma, and muscle soreness because it is associated with reduced swelling and discomfort after minor injuries. In Fisiocrem, arnica contributes to the relief of muscle pain and bruising, particularly following sports or accidental knocks.

Hypericum, or St John’s Wort, is included for its soothing effect on nerve‑related discomfort and its supportive role in soft tissue healing. Calendula is commonly used to promote tissue repair and calm irritated skin, making it a useful companion ingredient when treating minor muscle injuries and inflammation.

Melaleuca (tea tree) oil offers antimicrobial and mild anti‑inflammatory effects, which can be helpful when the skin is intact but the underlying tissues are strained or sore. Menthol provides an immediate cooling sensation that distracts from pain and increases local blood flow, which may assist muscle recovery and reduce the perception of soreness.

Mechanism of Action on Muscles

When applied to sore muscles, Fisiocrem works mainly through local, surface-level mechanisms rather than systemic absorption. The menthol component stimulates cold-sensitive receptors in the skin, creating a cooling feeling that competes with pain signals and can quickly lessen the sensation of discomfort.

At the same time, the herbal ingredients appear to support blood flow, reduce mild inflammation, and aid the healing of minor soft-tissue injuries such as strains, sprains, and post‑exercise microtrauma. Clinical data from a randomized, placebo‑controlled trial showed that regular application of Fisiocrem Solugel over 14 days was associated with reduced musculoskeletal pain and improved mobility, suggesting benefits for both acute and longer‑lasting muscle pain.

Use in Joint Pain and Mild Arthritis

Fisiocrem is also used to manage mild joint aches, stiffness, and symptoms associated with mild arthritis and osteoarthritis, especially in knees and other frequently loaded joints. The joint‑specific product typically combines the original muscle‑focused formula with additional ingredients like boswellia and nigella to further support joint mobility and reduce mild joint inflammation

These formulations are designed to be massaged into painful joints several times a day, providing temporary relief and helping maintain flexibility and day‑to‑day function. Although they are not disease‑modifying treatments for arthritis, they can form part of a broader management plan that may include exercise, weight control, and oral medications when needed.

Practical Application and Dosing

Fisiocrem gel is typically applied directly to the affected area in small amounts, with recommendations often suggesting use three to four times daily as required. Users are advised to massage a few grams into the skin until absorbed, avoiding contact with eyes, broken skin, or mucous membranes, and to wash hands afterward.

The product is widely used after sport, heavy physical work, or long periods of sitting to relieve tightness in the back, neck, shoulders, and legs. Because it is non‑greasy and absorbs quickly, people can usually apply it and then continue daily activities without significant residue or odour, which makes adherence easier.

Evidence and Benefits

A key strength of Fisiocrem is that its muscle gel has been studied in a randomized, double‑blind, placebo‑controlled trial, where participants applying it twice daily reported faster pain reduction and better mobility than those using a placebo cream. This trial indicated both an immediate effect, felt within minutes, and a sustained benefit over two weeks of regular use for musculoskeletal pain.

Beyond formal trials, Fisiocrem is widely used in clinical settings such as osteopathy, chiropractic, and sports therapy practices, where practitioners report benefits in easing muscle soreness, aiding recovery, and supporting treatment of minor sprains and strains. Sales data in some regions suggest it is among the more popular over‑the‑counter muscle pain relief gels, reflecting general consumer acceptance and perceived effectiveness.

Safety, Limitations, and Role in Care

For most adults, Fisiocrem is considered safe when used as directed, though people should always check the ingredient list for potential allergies, particularly to plant extracts or menthol. It can sometimes be used alongside other treatments, and some information notes that it may be appropriate even for people on blood‑thinning medications, but such combinations should still be discussed with a health professional when there is any doubt.

However, Fisiocrem is intended only for temporary relief of mild to moderate muscle and joint pain and is not a substitute for medical assessment of serious or persistent symptoms. Ongoing or worsening pain, significant swelling, joint deformity, or neurological symptoms such as numbness or weakness require prompt medical evaluation, with Fisiocrem, if used at all, serving only as a supportive measure in a broader treatment plan.

Formthotics are heat‑mouldable foot orthoses that clinicians use widely to manage common foot and lower‑limb problems. They work by improving alignment, redistributing pressure, and supporting the foot’s natural structures to reduce pain and improve function.

What Formthotics Are

Formthotics are prefabricated, medical‑grade foam insoles that can be custom‑shaped to a person’s feet and shoes using heat, usually in a clinic setting. The material (often referred to as Formax foam) is lightweight, closed‑cell and thermoformable, allowing the orthotic to contour closely to the arch and heel for a more personalized fit than a standard off‑the‑shelf insole. They are available in different densities, thicknesses and shapes so that practitioners can match support and cushioning levels to the patient’s condition and activity demands, from everyday walking to high‑impact sports.

How Formthotics Work Biomechanically

The key therapeutic effect of Formthotics lies in how they influence foot biomechanics, especially the way forces travel from the ground through the foot and up the leg. By providing a contoured arch, deep heel cup and stable base, they can help control excessive pronation or other abnormal foot motions that overload soft tissues and joints. This improved positioning of the foot alters ground reaction forces, often reducing torsion and compressive stress at the ankle, knee and hip, which can lessen pain and lower injury risk higher up the kinetic chain.

Formthotics also redistribute plantar pressure so that weight is spread more evenly across the foot instead of being concentrated under the heel, forefoot or medial arch. In people with flat feet, the additional arch support and stabilization help relieve strain on structures like the plantar fascia and tibialis posterior tendon. In those with high arches, the foam provides extra cushioning and shock absorption, reducing peak forces under the heel and forefoot and protecting against impact‑related pain.

Foot and Lower‑Limb Problems Treated

Clinicians use Formthotics to manage a wide range of mild to moderate foot and lower‑limb conditions. Common indications include plantar heel pain such as plantar fasciitis or “policeman’s heel,” where better arch support and heel cushioning help to offload the irritated fascia and reduce traction forces at its origin. They are also used for metatarsalgia (forefoot pain), where spreading load away from overloaded metatarsal heads can relieve symptoms during walking and running.

In children and adolescents, Formthotics may be prescribed for conditions such as Sever’s disease (calcaneal apophysitis) to reduce heel stress during growth and sports. Because they influence overall lower‑limb alignment, they are also used in the management of tibialis posterior dysfunction, shin splints, patellofemoral pain and knee osteoarthritis, where correcting excessive pronation and improving load distribution at the knee can reduce pain and improve function. Many clinics also use them as part of treatment for general foot fatigue, bunion‑related discomfort and nonspecific ankle or arch pain associated with long periods of standing or walking.

Examples of conditions and aims

Condition / issue	Main therapeutic aims with Formthotics
Flat feet / over‑pronation	Support arch, improve alignment, reduce strain on plantar fascia and tendons
High arches	Increase cushioning, reduce impact and focal pressure under heel/forefoot
Plantar fasciitis / heel pain	Offload plantar fascia, stabilize heel, reduce traction at fascia origin
Metatarsalgia (forefoot pain)	Redistribute forefoot pressure and support metatarsal arch
Shin splints / tibial stress	Control foot motion, reduce repetitive traction on tibial structures
Patellofemoral knee pain / OA	Improve foot mechanics to optimize knee alignment and load
General foot fatigue / standing	Provide cushioning, support, and improved posture during prolonged standing

Clinical Fitting and Treatment Process

The use of Formthotics starts with a clinical assessment to determine whether foot mechanics contribute to the patient’s symptoms. A therapist or podiatrist typically examines foot posture, joint mobility, gait and footwear, and may look at how pain changes under different loading conditions. If orthotic support is indicated, a suitable Formthotics model is selected based on foot shape, shoe type, body weight and activity level, and then heat‑moulded directly in the clinic so that it conforms closely to the patient’s feet and shoes within minutes.

After the initial moulding, the practitioner may add “posting” or small wedges to fine‑tune rearfoot or forefoot alignment, and can grind or modify the device for comfort and function as needed. Patients are usually advised to wear the orthoses for gradually increasing periods over several days so that the feet and legs can adapt to the new mechanics without excessive soreness. Follow‑up appointments are often scheduled to check symptom change, adjust fit, and integrate the orthoses into a broader plan that may include strengthening, stretching, load management and footwear changes.

Evidence and Advantages

Independent, peer‑reviewed research has shown that Formthotics can reduce pain, prevent certain injuries and improve comfort in both everyday and sporting populations. Clinicians value them because they combine some of the customizability of bespoke orthotics with the speed and cost advantages of prefabricated devices; heat‑moulding typically takes only a few minutes, allowing patients to leave the consultation with immediate changes in support and comfort. Their lightweight, plant‑based foam construction and contoured heel cup and arch design make them suitable for a wide variety of footwear, which encourages consistent use and therefore better long‑term outcomes.

Although no orthotic can guarantee injury prevention or complete symptom resolution, improving foot alignment and load distribution with Formthotics can significantly reduce common risk factors for overuse injuries like plantar fasciitis and tibial stress syndromes. They are particularly useful for people whose pain is clearly aggravated by prolonged standing, walking or running and whose symptoms improve when the foot is better supported or cushioned. For optimal results, Formthotics are best used as one component of a comprehensive management plan that addresses strength, flexibility, training load and appropriate footwear rather than as a stand‑alone cure.

Using the Fasciitis Fighter focuses on strengthening and loading the plantar fascia rather than simply resting it. This approach aims to improve tissue capacity and reduce pain over time.

What plantar fasciitis is

Plantar fasciitis involves irritation and micro-tearing of the plantar fascia, a thick band of tissue running from the heel to the toes. It commonly causes sharp heel pain, especially with the first steps in the morning or after prolonged sitting.

The condition is usually related to excessive load on the fascia from factors such as increased activity, reduced calf flexibility, poor footwear, or prolonged standing. Most evidence-based treatments aim either to reduce load temporarily or to improve the tissue’s ability to tolerate load.

What the Fasciitis Fighter is

The Fasciitis Fighter is a firm, curved EVA foam device designed specifically to help with plantar fasciitis–related heel pain. Its shape allows the big toe to be held in extension while the user performs strengthening or stretching exercises.

The original device is sized for single-foot exercises, while the ROUND 2 version is longer to allow bilateral work and balance tasks. It is marketed as an evidence-based strengthening aid trusted by health professionals and sports teams and intended to complement, not replace, professional care.

Rationale: high-load strengthening

Research supports high-load strength training for plantar fasciitis, where the plantar fascia is loaded in a controlled, progressive way to improve its capacity and tolerance. Holding the big toe in extension uses the windlass mechanism, placing tension on the fascia while the calf and foot muscles work.

Over at least 12 weeks, this type of loading can help the fascia cope better with daily stresses and is associated with faster pain reduction and functional improvement than some passive treatments. The Fasciitis Fighter’s main purpose is to make this specific high-load exercise easier and more consistent than using a rolled towel.

How the device is used

A typical strengthening drill involves placing the big toe on the Fasciitis Fighter so it is extended, then performing slow calf raises to load the plantar fascia and calf muscles. The exercise is usually progressed by increasing load (for example using a backpack or doing it on one leg) and adjusting sets and repetitions under professional guidance.

The device can also be used for calf and plantar fascia stretching by standing with the toes extended over it and leaning forward with straight and bent knees to target different calf muscles. ROUND 2 models can be used for balance and intrinsic foot muscle activation by standing along the hump and maintaining stability

Benefits and limitations in treatment

Using the Fasciitis Fighter may help reduce heel pain by improving plantar fascia strength, enhancing big-toe mobility, and supporting better overall foot function. Many clinics use it as part of home programs to allow patients to self-manage heel and arch pain between visits.

However, it is not a stand‑alone cure and does not replace a full assessment; factors such as footwear, training load, weight, and calf flexibility still need addressing. The product itself notes that it exists to help complete a strengthening exercise for temporary pain relief and should be used under the guidance of a health professional, with loading parameters individualized.

Place in a broader management plan

In practice, the Fasciitis Fighter is commonly combined with other conservative treatments such as plantar fascia–specific stretching, activity modification, ice, and sometimes taping or orthoses. Reviews of plantar fasciitis management suggest that such active, exercise-based approaches can be more effective long term than relying solely on injections or passive modalities.

Compared with improvised tools like towels, a purpose‑built device can improve convenience, consistency, and patient adherence to the high‑load program. When used regularly over several months as part of a structured plan, it can be a useful tool in reducing pain and restoring function in people with plantar fasciitis.